Browse
Explore conditions, clinical trials, and the organisations running them.
7285 conditions with clinical trials.
- Malignant glioma 3393 trials
- Female reproductive system neoplasm 3381 trials
- Esophageal cancer 3315 trials
- Prostate neoplasm 3303 trials
- Estrogen-receptor positive breast cancer 3283 trials
- Kidney cancer 3277 trials
- Skin cancer 3257 trials
- Bone neoplasm 3245 trials
- Cervical cancer 3233 trials
- Rectal cancer 3227 trials
- Renal carcinoma 3224 trials
- Biliary tract cancer 3220 trials
- Malignant epithelial tumor of ovary 3204 trials
- Neuroendocrine carcinoma 3201 trials
- Head and neck neoplasm 3197 trials
- Ovarian carcinoma 3194 trials
- Estrogen-receptor negative breast cancer 3193 trials
- High grade astrocytic tumor 3193 trials
- Progesterone-receptor negative breast cancer 3191 trials
- Triple-negative breast carcinoma 3191 trials
- Renal cell carcinoma 3183 trials
- Transitional cell carcinoma 3181 trials
- Uterine carcinoma 3180 trials
- Metastatic prostate carcinoma 3175 trials
- Urothelial carcinoma 3175 trials
- Glioblastoma 3173 trials
- Colorectal adenocarcinoma 3169 trials
- Endometrial cancer 3168 trials
- Progesterone-receptor positive breast cancer 3167 trials
- Urinary bladder cancer 3166 trials
- Pharynx cancer 3165 trials
- Childhood acute lymphoblastic leukemia 3160 trials
- Urinary bladder carcinoma 3160 trials
- Soft tissue sarcoma 3150 trials
- Hormone receptor-positive breast cancer 3146 trials
- Pancreatic ductal adenocarcinoma 3146 trials
- B-cell childhood acute lymphoblastic leukemia 3144 trials
- Gastric carcinoma 3140 trials
- Malignant soft tissue neoplasm 3128 trials
- Metastatic malignant neoplasm in the brain 3128 trials
- Bile duct cancer 3120 trials
- Childhood leukemia 3116 trials
- Pediatric lymphoma 3116 trials
- Bile duct carcinoma 3115 trials
- Primary mediastinal large B-cell lymphoma 3115 trials
- Central nervous system neoplasm 3113 trials
- Carcinoma of esophagus 3105 trials
- Invasive carcinoma 3102 trials
- Extrahepatic bile duct carcinoma 3095 trials
- Chronic myelogenous leukemia, BCR-ABL1 positive 3091 trials